UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Chong Kun Dang, Dongkook lead functional foods
by Nam Doo-hyun
2018-08-27 15:42
I-Mab to start trials for Genexine’s diabetes treatment
by Lee Han-soo
2018-08-27 14:40
‘Xeomin’s side effect lowest among 5 botulinum toxins’
by Nam Doo-hyun
2018-08-27 14:39
Korean doctors favor original drugs after valsartan incident: survey
by Lee Han-soo
2018-08-27 14:38
JW licenses out atopy treatment to Leo Pharma
by Lee Han-soo
2018-08-24 16:08
라인
DongA unveils new foot fungus treatment
by Lee Han-soo
2018-08-24 14:34
Gilead’s Genvoya comfortably tops HIV treatments
by Nam Doo-hyun
2018-08-24 14:33
Roche Diagnostics donates ₩15 mil. to prevent child abuse
by Marian Chu
2018-08-24 12:10
Hana Pharm performs P3 tests for new anesthetic agent
by Marian Chu
2018-08-23 17:31
Boryung launches rapid influenza diagnostic kit
by Marian Chu
2018-08-23 16:46
라인
Ildong, Sandoz to ally in Asia-Pacific
by Marian Chu
2018-08-23 15:11
Myungmoon Pharm’s valsartan additionally suspended
by Lee Hye-seon
2018-08-23 15:10
3 multinationals refuse to take pharma group’s anti-corruption system
by Nam Doo-hyun
2018-08-23 12:01
Dong-A ST, Takara Bio signs licensing agreement for oncolytic virus therapy
by Marian Chu
2018-08-23 11:49
Bridge Biotherapeutics presents preclinical trial results on ATX inhibitor
by Marian Chu
2018-08-23 10:31
라인
5 Korean biopharmaceuticals most active in P3 trials in 5 years
by Marian Chu
2018-08-23 10:31
Foreign CEOs to lead Korean units of Novartis, Galderma
by Nam Doo-hyun
2018-08-22 13:56
Boehringer Ingelheim to present sub-analyses on Pradaxa at ESC Congress 2018
by Marian Chu
2018-08-22 12:31
Lixiana faces patent challenge in substance, composition
by Lee Hye-seon
2018-08-22 11:16
Shire Korea gets approval for short bowel syndrome treatment
by Marian Chu
2018-08-22 11:15
-
이전
71
72
73
74
75
76
77
78
79
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top